Combined	combined	O	O	O	O
antiretroviral	antiretroviral	O	O	O	O
therapy	therapy	O	O	O	O
causes	causes	O	O	O	O
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
elevates	elevates	O	O	O	O
plasma	plasma	O	O	O	O
lactate	lactate	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
transgenic	transgenic	O	O	O	O
AIDS	aids	O	DISEASE	OTHERS	I
mice	mice	O	O	O	O
.	.	O	O	O	O

Highly	highly	O	O	O	O
active	active	O	O	O	O
antiretroviral	antiretroviral	O	O	O	O
therapy	therapy	O	O	O	O
(	(	O	O	O	O
HAART	haart	O	O	O	O
)	)	O	O	O	O
is	is	O	O	O	O
implicated	implicated	O	O	O	O
in	in	O	O	O	O
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
(	(	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
elevated	elevated	O	O	O	O
plasma	plasma	O	O	O	O
lactate	lactate	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
LA	la	O	O	OTHERS	I
)	)	O	O	O	O
in	in	O	O	O	O
AIDS	aids	O	DISEASE	OTHERS	I
through	through	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
mitochondrial	mitochondrial	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

To	to	O	O	O	O
determine	determine	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
events	events	O	O	O	O
from	from	O	O	O	O
HAART	haart	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
,	,	O	O	O	O
8-week-old	8-week-old	O	O	O	O
hemizygous	hemizygous	O	O	O	O
transgenic	transgenic	O	O	O	O
AIDS	aids	O	DISEASE	OTHERS	I
mice	mice	O	O	O	O
(	(	O	O	O	O
NL4	nl4	O	O	O	O
-	-	O	O	O	O
3Delta	3delta	O	O	O	O
gag/pol	gag/pol	O	O	O	O
;	;	O	O	O	O
TG	tg	O	DISEASE	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
wild-type	wild-type	O	O	O	O
FVB/n	fvb/n	O	O	O	O
littermates	littermates	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
HAART	haart	O	O	O	O
combination	combination	O	O	O	O
of	of	O	O	O	O
zidovudine	zidovudine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
lamivudine	lamivudine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
indinavir	indinavir	CHEMICALS	O	OTHERS	I
or	or	O	O	O	O
vehicle	vehicle	O	O	O	O
control	control	O	O	O	O
for	for	O	O	O	O
10	10	O	O	O	O
days	days	O	O	O	O
or	or	O	O	O	O
35	35	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

At	at	O	O	O	O
termination	termination	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
experiments	experiments	O	O	O	O
,	,	O	O	O	O
mice	mice	O	O	O	O
underwent	underwent	O	O	O	O
echocardiography	echocardiography	O	O	O	O
,	,	O	O	O	O
quantitation	quantitation	O	O	O	O
of	of	O	O	O	O
abundance	abundance	O	O	O	O
of	of	O	O	O	O
molecular	molecular	O	O	O	O
markers	markers	O	O	O	O
of	of	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
(	(	O	O	O	O
ventricular	ventricular	O	O	O	O
mRNA	mrna	O	O	O	O
encoding	encoding	O	O	O	O
atrial	atrial	CHEMICALS	O	OTHERS	I
natriuretic	natriuretic	CHEMICALS	O	OTHERS	I
factor	factor	CHEMICALS	O	OTHERS	I
[	[	O	O	O	O
ANF	anf	CHEMICALS	O	OTHERS	I
]	]	O	O	O	O
and	and	O	O	O	O
sarcoplasmic	sarcoplasmic	O	O	O	O
calcium	calcium	CHEMICALS	O	OTHERS	I
ATPase	atpase	O	O	O	O
[	[	O	O	O	O
SERCA2	serca2	O	O	O	O
]	]	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
determination	determination	O	O	O	O
of	of	O	O	O	O
plasma	plasma	O	O	O	O
LA	la	O	O	OTHERS	I
.	.	O	O	O	O

Myocardial	myocardial	O	O	O	O
histologic	histologic	O	O	O	O
features	features	O	O	O	O
were	were	O	O	O	O
analyzed	analyzed	O	O	O	O
semiquantitatively	semiquantitatively	O	O	O	O
and	and	O	O	O	O
results	results	O	O	O	O
were	were	O	O	O	O
confirmed	confirmed	O	O	O	O
by	by	O	O	O	O
transmission	transmission	O	O	O	O
electron	electron	O	O	O	O
microscopy	microscopy	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
35	35	O	O	O	O
days	days	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
TG	tg	O	DISEASE	OTHERS	I
+	+	O	O	O	O
HAART	haart	O	O	O	O
cohort	cohort	O	O	O	O
,	,	O	O	O	O
left	left	O	O	O	O
ventricular	ventricular	O	O	O	O
mass	mass	O	O	O	O
increased	increased	O	O	O	O
160	160	O	O	O	O
%	%	O	O	O	O
by	by	O	O	O	O
echocardiography	echocardiography	O	O	O	O
.	.	O	O	O	O

Molecularly	molecularly	O	O	O	O
,	,	O	O	O	O
ANF	anf	CHEMICALS	O	OTHERS	I
mRNA	mrna	O	O	O	O
increased	increased	O	O	O	O
250	250	O	O	O	O
%	%	O	O	O	O
and	and	O	O	O	O
SERCA2	serca2	O	O	O	O
mRNA	mrna	O	O	O	O
decreased	decreased	O	O	O	O
57	57	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

Biochemically	biochemically	O	O	O	O
,	,	O	O	O	O
LA	la	O	O	OTHERS	I
was	was	O	O	O	O
elevated	elevated	O	O	O	O
(	(	O	O	O	O
8.5	8.5	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2.0	2.0	O	O	O	O
mM	mm	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Pathologically	pathologically	O	O	O	O
,	,	O	O	O	O
granular	granular	O	O	O	O
cytoplasmic	cytoplasmic	O	O	O	O
changes	changes	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
cardiac	cardiac	O	O	O	O
myocytes	myocytes	O	O	O	O
,	,	O	O	O	O
indicating	indicating	O	O	O	O
enlarged	enlarged	O	O	O	O
,	,	O	O	O	O
damaged	damaged	O	O	O	O
mitochondria	mitochondria	O	O	O	O
.	.	O	O	O	O

Findings	findings	O	O	O	O
were	were	O	O	O	O
confirmed	confirmed	O	O	O	O
ultrastructurally	ultrastructurally	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
changes	changes	O	O	O	O
were	were	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
other	other	O	O	O	O
cohorts	cohorts	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
10	10	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
only	only	O	O	O	O
ANF	anf	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
elevated	elevated	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
only	only	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
TG	tg	O	DISEASE	OTHERS	I
+	+	O	O	O	O
HAART	haart	O	O	O	O
cohort	cohort	O	O	O	O
.	.	O	O	O	O

Results	results	O	O	O	O
show	show	O	O	O	O
that	that	O	O	O	O
cumulative	cumulative	O	O	O	O
HAART	haart	O	O	O	O
caused	caused	O	O	O	O
mitochondrial	mitochondrial	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
with	with	O	O	O	O
elevated	elevated	O	O	O	O
LA	la	O	O	OTHERS	I
in	in	O	O	O	O
AIDS	aids	O	DISEASE	OTHERS	I
transgenic	transgenic	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

